Global Apomorphine Hydrochloride 麻豆原创 Growth 2025-2031

Publication ID:

LPI01250696

Publication Date:

January 8, 2025

Pages:

105

Publisher:

LPI

Countries:

Global [1]

USD 3,660.00

Pharmaceutical Manufacturing [2]

Healthcare [3]

Pharma & Healthcare [4]

Description:

The global Apomorphine Hydrochloride market size is predicted to grow from US$ 293 million in 2025 to US$ 372 million in 2031; it is expected to grow at a CAGR of 4.0% from 2025 to 2031.
Apomorphine is a non-selective dopamine agonist which activates both D2-like and, to a much lesser extent, D1-like receptors. It also acts as an antagonist of 5-HT2 and 伪-adrenergic receptors with high affinity. The compound is historically a morphine decomposition product made by boiling morphine with concentrated acid, hence the -morphine suffix. Apomorphine does not actually contain morphine or its skeleton, nor does it bind to opioid receptors.
The classification of Apomorphine Hydrochloride includes Injection, Tablets, Thinfilm, etc and the proportion of Injection in 2019 is about 89.88%, and the proportion is in decreasing trend from 2020 to 2025.
Apomorphine Hydrochloride is widely used through Parkinson Disease and Erectile Dysfunction. The most proportion of Apomorphine Hydrochloride is used for Parkinson Disease, and the sales proportion in 2019 is 89.88%.
Europe is the largest consumption place, with a consumption market share nearly 54.19% in 2019. Following Europe, North America is the second largest consumption place with the consumption market share of 23.69%.
麻豆原创 competition is not intense. Supernus Pharmaceuticals, Britannia Pharmaceuticals STADA, Ever Pharma are the leaders of the industry, and they hold key technologies and patents, with high-end customers.
The 鈥淎pomorphine Hydrochloride Industry Forecast鈥� looks at past sales and reviews total world Apomorphine Hydrochloride sales in 2024, providing a comprehensive analysis by region and market sector of projected Apomorphine Hydrochloride sales for 2025 through 2031. With Apomorphine Hydrochloride sales broken down by region, market sector and sub-sector, this report provides a detailed analysis in US$ millions of the world Apomorphine Hydrochloride industry.
This Insight Report provides a comprehensive analysis of the global Apomorphine Hydrochloride landscape and highlights key trends related to product segmentation, company formation, revenue, and market share, latest development, and M&A activity. This report also analyzes the strategies of leading global companies with a focus on Apomorphine Hydrochloride portfolios and capabilities, market entry strategies, market positions, and geographic footprints, to better understand these firms鈥� unique position in an accelerating global Apomorphine Hydrochloride market.
This Insight Report evaluates the key market trends, drivers, and affecting factors shaping the global outlook for Apomorphine Hydrochloride and breaks down the forecast by Type, by Application, geography, and market size to highlight emerging pockets of opportunity. With a transparent methodology based on hundreds of bottom-up qualitative and quantitative market inputs, this study forecast offers a highly nuanced view of the current state and future trajectory in the global Apomorphine Hydrochloride.
This report presents a comprehensive overview, market shares, and growth opportunities of Apomorphine Hydrochloride market by product type, application, key manufacturers and key regions and countries.
Segmentation by Type:
Injection
Tablets
Thinfilm
Nasal Powder (Pipeline)
Segmentation by Application:
Parkinson Disease
Erectile Dysfunction
This report also splits the market by region:
Americas
United States
Canada
Mexico
Brazil
APAC
China
Japan
Korea
Southeast Asia
India
Australia
Europe
Germany
France
UK
Italy
Russia
Middle East & Africa
Egypt
South Africa
Israel
Turkey
GCC Countries
The below companies that are profiled have been selected based on inputs gathered from primary experts and analysing the company's coverage, product portfolio, its market penetration.
Supernus Pharmaceuticals
Britannia Pharmaceuticals STADA
Ever Pharma
Evolan Pharma AB (PharmSwed)
Tianjin Tianwei Pharmaceutical
Sunovion
Key Questions Addressed in this Report
What is the 10-year outlook for the global Apomorphine Hydrochloride market?
What factors are driving Apomorphine Hydrochloride market growth, globally and by region?
Which technologies are poised for the fastest growth by market and region?
How do Apomorphine Hydrochloride market opportunities vary by end market size?
How does Apomorphine Hydrochloride break out by Type, by Application?

Please Note - This is an on demand report and will be delivered in 2 business days (48 hours) post payment.

Table Of Contents:

1 Scope of the Report
1.1 麻豆原创 Introduction
1.2 Years Considered
1.3 Research Objectives
1.4 麻豆原创 Research Methodology
1.5 Research Process and Data Source
1.6 Economic Indicators
1.7 Currency Considered
1.8 麻豆原创 Estimation Caveats
2 Executive Summary
2.1 World 麻豆原创 Overview
2.1.1 Global Apomorphine Hydrochloride Annual Sales 2020-2031
2.1.2 World Current & Future Analysis for Apomorphine Hydrochloride by Geographic Region, 2020, 2024 & 2031
2.1.3 World Current & Future Analysis for Apomorphine Hydrochloride by Country/Region, 2020, 2024 & 2031
2.2 Apomorphine Hydrochloride Segment by Type
2.2.1 Injection
2.2.2 Tablets
2.2.3 Thinfilm
2.2.4 Nasal Powder (Pipeline)
2.3 Apomorphine Hydrochloride Sales by Type
2.3.1 Global Apomorphine Hydrochloride Sales 麻豆原创 Share by Type (2020-2025)
2.3.2 Global Apomorphine Hydrochloride Revenue and 麻豆原创 Share by Type (2020-2025)
2.3.3 Global Apomorphine Hydrochloride Sale Price by Type (2020-2025)
2.4 Apomorphine Hydrochloride Segment by Application
2.4.1 Parkinson Disease
2.4.2 Erectile Dysfunction
2.5 Apomorphine Hydrochloride Sales by Application
2.5.1 Global Apomorphine Hydrochloride Sale 麻豆原创 Share by Application (2020-2025)
2.5.2 Global Apomorphine Hydrochloride Revenue and 麻豆原创 Share by Application (2020-2025)
2.5.3 Global Apomorphine Hydrochloride Sale Price by Application (2020-2025)
3 Global by Company
3.1 Global Apomorphine Hydrochloride Breakdown Data by Company
3.1.1 Global Apomorphine Hydrochloride Annual Sales by Company (2020-2025)
3.1.2 Global Apomorphine Hydrochloride Sales 麻豆原创 Share by Company (2020-2025)
3.2 Global Apomorphine Hydrochloride Annual Revenue by Company (2020-2025)
3.2.1 Global Apomorphine Hydrochloride Revenue by Company (2020-2025)
3.2.2 Global Apomorphine Hydrochloride Revenue 麻豆原创 Share by Company (2020-2025)
3.3 Global Apomorphine Hydrochloride Sale Price by Company
3.4 Key Manufacturers Apomorphine Hydrochloride Producing Area Distribution, Sales Area, Product Type
3.4.1 Key Manufacturers Apomorphine Hydrochloride Product Location Distribution
3.4.2 Players Apomorphine Hydrochloride Products Offered
3.5 麻豆原创 Concentration Rate Analysis
3.5.1 Competition Landscape Analysis
3.5.2 Concentration Ratio (CR3, CR5 and CR10) & (2023-2025)
3.6 New Products and Potential Entrants
3.7 麻豆原创 M&A Activity & Strategy
4 World Historic Review for Apomorphine Hydrochloride by Geographic Region
4.1 World Historic Apomorphine Hydrochloride 麻豆原创 Size by Geographic Region (2020-2025)
4.1.1 Global Apomorphine Hydrochloride Annual Sales by Geographic Region (2020-2025)
4.1.2 Global Apomorphine Hydrochloride Annual Revenue by Geographic Region (2020-2025)
4.2 World Historic Apomorphine Hydrochloride 麻豆原创 Size by Country/Region (2020-2025)
4.2.1 Global Apomorphine Hydrochloride Annual Sales by Country/Region (2020-2025)
4.2.2 Global Apomorphine Hydrochloride Annual Revenue by Country/Region (2020-2025)
4.3 Americas Apomorphine Hydrochloride Sales Growth
4.4 APAC Apomorphine Hydrochloride Sales Growth
4.5 Europe Apomorphine Hydrochloride Sales Growth
4.6 Middle East & Africa Apomorphine Hydrochloride Sales Growth
5 Americas
5.1 Americas Apomorphine Hydrochloride Sales by Country
5.1.1 Americas Apomorphine Hydrochloride Sales by Country (2020-2025)
5.1.2 Americas Apomorphine Hydrochloride Revenue by Country (2020-2025)
5.2 Americas Apomorphine Hydrochloride Sales by Type (2020-2025)
5.3 Americas Apomorphine Hydrochloride Sales by Application (2020-2025)
5.4 United States
5.5 Canada
5.6 Mexico
5.7 Brazil
6 APAC
6.1 APAC Apomorphine Hydrochloride Sales by Region
6.1.1 APAC Apomorphine Hydrochloride Sales by Region (2020-2025)
6.1.2 APAC Apomorphine Hydrochloride Revenue by Region (2020-2025)
6.2 APAC Apomorphine Hydrochloride Sales by Type (2020-2025)
6.3 APAC Apomorphine Hydrochloride Sales by Application (2020-2025)
6.4 China
6.5 Japan
6.6 South Korea
6.7 Southeast Asia
6.8 India
6.9 Australia
6.10 China Taiwan
7 Europe
7.1 Europe Apomorphine Hydrochloride by Country
7.1.1 Europe Apomorphine Hydrochloride Sales by Country (2020-2025)
7.1.2 Europe Apomorphine Hydrochloride Revenue by Country (2020-2025)
7.2 Europe Apomorphine Hydrochloride Sales by Type (2020-2025)
7.3 Europe Apomorphine Hydrochloride Sales by Application (2020-2025)
7.4 Germany
7.5 France
7.6 UK
7.7 Italy
7.8 Russia
8 Middle East & Africa
8.1 Middle East & Africa Apomorphine Hydrochloride by Country
8.1.1 Middle East & Africa Apomorphine Hydrochloride Sales by Country (2020-2025)
8.1.2 Middle East & Africa Apomorphine Hydrochloride Revenue by Country (2020-2025)
8.2 Middle East & Africa Apomorphine Hydrochloride Sales by Type (2020-2025)
8.3 Middle East & Africa Apomorphine Hydrochloride Sales by Application (2020-2025)
8.4 Egypt
8.5 South Africa
8.6 Israel
8.7 Turkey
8.8 GCC Countries
9 麻豆原创 Drivers, Challenges and Trends
9.1 麻豆原创 Drivers & Growth Opportunities
9.2 麻豆原创 Challenges & Risks
9.3 Industry Trends
10 Manufacturing Cost Structure Analysis
10.1 Raw Material and Suppliers
10.2 Manufacturing Cost Structure Analysis of Apomorphine Hydrochloride
10.3 Manufacturing Process Analysis of Apomorphine Hydrochloride
10.4 Industry Chain Structure of Apomorphine Hydrochloride
11 麻豆原创ing, Distributors and Customer
11.1 Sales Channel
11.1.1 Direct Channels
11.1.2 Indirect Channels
11.2 Apomorphine Hydrochloride Distributors
11.3 Apomorphine Hydrochloride Customer
12 World Forecast Review for Apomorphine Hydrochloride by Geographic Region
12.1 Global Apomorphine Hydrochloride 麻豆原创 Size Forecast by Region
12.1.1 Global Apomorphine Hydrochloride Forecast by Region (2026-2031)
12.1.2 Global Apomorphine Hydrochloride Annual Revenue Forecast by Region (2026-2031)
12.2 Americas Forecast by Country (2026-2031)
12.3 APAC Forecast by Region (2026-2031)
12.4 Europe Forecast by Country (2026-2031)
12.5 Middle East & Africa Forecast by Country (2026-2031)
12.6 Global Apomorphine Hydrochloride Forecast by Type (2026-2031)
12.7 Global Apomorphine Hydrochloride Forecast by Application (2026-2031)
13 Key Players Analysis
13.1 Supernus Pharmaceuticals
13.1.1 Supernus Pharmaceuticals Company Information
13.1.2 Supernus Pharmaceuticals Apomorphine Hydrochloride Product Portfolios and Specifications
13.1.3 Supernus Pharmaceuticals Apomorphine Hydrochloride Sales, Revenue, Price and Gross Margin (2020-2025)
13.1.4 Supernus Pharmaceuticals Main Business Overview
13.1.5 Supernus Pharmaceuticals Latest Developments
13.2 Britannia Pharmaceuticals STADA
13.2.1 Britannia Pharmaceuticals STADA Company Information
13.2.2 Britannia Pharmaceuticals STADA Apomorphine Hydrochloride Product Portfolios and Specifications
13.2.3 Britannia Pharmaceuticals STADA Apomorphine Hydrochloride Sales, Revenue, Price and Gross Margin (2020-2025)
13.2.4 Britannia Pharmaceuticals STADA Main Business Overview
13.2.5 Britannia Pharmaceuticals STADA Latest Developments
13.3 Ever Pharma
13.3.1 Ever Pharma Company Information
13.3.2 Ever Pharma Apomorphine Hydrochloride Product Portfolios and Specifications
13.3.3 Ever Pharma Apomorphine Hydrochloride Sales, Revenue, Price and Gross Margin (2020-2025)
13.3.4 Ever Pharma Main Business Overview
13.3.5 Ever Pharma Latest Developments
13.4 Evolan Pharma AB (PharmSwed)
13.4.1 Evolan Pharma AB (PharmSwed) Company Information
13.4.2 Evolan Pharma AB (PharmSwed) Apomorphine Hydrochloride Product Portfolios and Specifications
13.4.3 Evolan Pharma AB (PharmSwed) Apomorphine Hydrochloride Sales, Revenue, Price and Gross Margin (2020-2025)
13.4.4 Evolan Pharma AB (PharmSwed) Main Business Overview
13.4.5 Evolan Pharma AB (PharmSwed) Latest Developments
13.5 Tianjin Tianwei Pharmaceutical
13.5.1 Tianjin Tianwei Pharmaceutical Company Information
13.5.2 Tianjin Tianwei Pharmaceutical Apomorphine Hydrochloride Product Portfolios and Specifications
13.5.3 Tianjin Tianwei Pharmaceutical Apomorphine Hydrochloride Sales, Revenue, Price and Gross Margin (2020-2025)
13.5.4 Tianjin Tianwei Pharmaceutical Main Business Overview
13.5.5 Tianjin Tianwei Pharmaceutical Latest Developments
13.6 Sunovion
13.6.1 Sunovion Company Information
13.6.2 Sunovion Apomorphine Hydrochloride Product Portfolios and Specifications
13.6.3 Sunovion Apomorphine Hydrochloride Sales, Revenue, Price and Gross Margin (2020-2025)
13.6.4 Sunovion Main Business Overview
13.6.5 Sunovion Latest Developments
14 Research Findings and Conclusion

License Types:

Single User License (PDF)

This license allows for use of a publication by one person.
This person may print out a single copy of the publication.
This person can include information given in the publication in presentations and internal reports by providing full copyright credit to the publisher.
This person cannot share the publication (or any information contained therein) with any other person or persons.
Unless a Enterprise License is purchased, a Single User License must be purchased for every person that wishes to use the publication within the same organization.
Customers who infringe these license terms are liable for a Global license fee.

听

Site License (PDF)*

This license allows for use of a publication by all users within one corporate location, e.g. a regional office.
These users may print out a single copy of the publication.
These users can include information given in the publication in presentations and internal reports by providing full copyright credit to the publisher.
These users cannot share the publication (or any information contained therein) with any other person or persons outside the corporate location for which the publication is purchased.
Unless a Enterprise License is purchased, a Site User License must be purchased for every corporate location by an organization that wishes to use the publication within the same organization.
Customers who infringe these license terms are liable for a Global license fee.

听

Global License (PDF)*

This license allows for use of a publication by unlimited users within the purchasing organization e.g. all employees of a single company.
Each of these people may use the publication on any computer, and may print out the report, but may not share the publication (or any information contained therein) with any other person or persons outside of the organization.
These employees of purchasing organization can include information given in the publication in presentations and internal reports by providing full copyright credit to the publisher.

*If Applicable.